CRSBP-1/LYVE-l-null mice exhibit identifiable morphological and functional alterations of lymphatic capillary vessels.
about
ALK1 signaling regulates early postnatal lymphatic vessel developmentHyaluronan, Inflammation, and Breast Cancer ProgressionThe lymphatic system in health and disease.A role for all-trans-retinoic acid in the early steps of lymphatic vasculature development.Hyaluronan as an immune regulator in human diseases.CRSBP-1/LYVE-1 ligands disrupt lymphatic intercellular adhesion by inducing tyrosine phosphorylation and internalization of VE-cadherin.Aberrant lymphatic endothelial progenitors in lymphatic malformation developmentHyaluronan as a therapeutic target in human diseasesEctodomain Shedding of Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE-1) Is Induced by Vascular Endothelial Growth Factor A (VEGF-A)Low-molecular-weight hyaluronan (LMW-HA) accelerates lymph node metastasis of melanoma cells by inducing disruption of lymphatic intercellular adhesion.CRSBP-1/LYVE-1 ligands stimulate contraction of the CRSBP-1-associated ER network in lymphatic endothelial cells.Development of the LYVE-1 Gene with An Acidic-amino-acid-rich (AAAR) Domain in Evolution Is Associated with Acquisition of Lymph Nodes and Efficient Adaptive Immunity.Immunohistochemical examination on the distribution of cells expressed lymphatic endothelial marker podoplanin and LYVE-1 in the mouse tongue tissue.A mechanism of sialylation functionally silences the hyaluronan receptor LYVE-1 in lymphatic endothelium.The shedded ectodomain of Lyve-1 expressed on M2-like tumor-associated macrophages inhibits melanoma cell proliferation.
P2860
Q24316206-BB020155-88AA-481D-BB84-2FF8EC42367BQ27006607-05A608F4-D0DE-41DD-B2F6-5A5FB3E97810Q34015299-95192B58-7E3C-45B3-8C92-26C8DDD56A41Q34382211-851FD9D2-B0E5-4B31-ABEB-1ABD08DF00E3Q34636380-2DFA3A25-1403-4FF7-95AC-B7A0C7AF37C8Q34727910-72227E95-6E74-4B4E-9B48-94827049273FQ35568132-AAEEEB1C-7E7F-4FC3-948D-26FBB0B91A78Q36578627-530CE374-5BDC-490C-A91F-D2066A68E234Q36898186-741D5B18-2999-4FEC-9BFD-F8534679D618Q39079697-56C3B7C0-35DC-4689-9250-79983FB9A4ECQ39335938-CF1DBFFA-6B0F-4F1B-B13F-9D6CDC2E880DQ40073882-5D509378-1F4B-4AEC-AD9E-6C4D88F59FB9Q40733639-D2A762F8-CFCA-450B-A13A-26205C025F4BQ45411008-8AA3CB24-B9EE-459B-BCC8-A98856E4A828Q47270219-5D94A1C7-15FA-4175-89E9-4960B8BB2857
P2860
CRSBP-1/LYVE-l-null mice exhibit identifiable morphological and functional alterations of lymphatic capillary vessels.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
CRSBP-1/LYVE-l-null mice exhib ...... f lymphatic capillary vessels.
@ast
CRSBP-1/LYVE-l-null mice exhib ...... f lymphatic capillary vessels.
@en
type
label
CRSBP-1/LYVE-l-null mice exhib ...... f lymphatic capillary vessels.
@ast
CRSBP-1/LYVE-l-null mice exhib ...... f lymphatic capillary vessels.
@en
prefLabel
CRSBP-1/LYVE-l-null mice exhib ...... f lymphatic capillary vessels.
@ast
CRSBP-1/LYVE-l-null mice exhib ...... f lymphatic capillary vessels.
@en
P2093
P2860
P1433
P1476
CRSBP-1/LYVE-l-null mice exhib ...... f lymphatic capillary vessels.
@en
P2093
Frank E Johnson
Jung S Huang
Maulik R Shah
Tracy Smith
P2860
P304
P356
10.1016/J.FEBSLET.2006.10.028
P407
P577
2006-10-20T00:00:00Z